The Prostate Cancer Foundation (PCF) and Robert F. Smith, chairman and CEO of Vista Equity Partners are supporting research on a new non-invasive genetic test to determine a man’s risk of developing prostate cancer. Named the Smith Polygenic Risk Test for Prostate Cancer, the tool is part of PCF’s large initiative to reduce prostate cancer disparities in African American men, who are 76% more likely to develop prostate cancer than Caucasians, and twice as likely…
You must be logged in to read/download the full post.
The post Collaboration Seeks to Reduce Prostate Cancer Disparities in African Americans appeared first on BioNewsFeeds.